Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 22, 2026
Why Is Badger Meter (BMI) Stock Down -11.89% Today?

Why Is Badger Meter (BMI) Stock Down -11.89% Today?

Key Takeaways

  • Badger Meter shares plummeted approximately 11.89% on Wednesday, July 22, 2026, falling from a prior close of $145.87 to roughly $128.53 in afternoon trading.
  • The primary catalyst was the company's Q2 2026 earnings report, which showed a 7% year-over-year revenue decline and a 13% drop in diluted EPS, despite meeting analyst consensus estimates.
  • Management's cautious "flattish" full-year organic revenue guidance disappointed investors who had hoped for a stronger second-half recovery trajectory.
  • Margin compression, lower free cash flow, and ongoing AMI project pacing uncertainty compounded negative sentiment around the water technology company.
  • Broader industrial and water infrastructure sector weakness added to the selling pressure, with elevated trading volume confirming institutional repositioning.
  • Traders are now focused on whether awarded municipal projects ramp as scheduled in H2 2026 and whether cost pressures from electronics components ease.

Opening Summary

BMI, the stock of Badger Meter, Inc. — a Milwaukee-based global manufacturer of flow measurement, water quality, and control solutions for municipal water utilities and industrial customers — suffered a sharp decline of approximately 11.89% in Wednesday's trading session. The stock fell from a previous close of $145.87 to roughly $128.53 as of mid-afternoon, erasing a significant portion of recent gains. The sell-off was triggered by the company's second quarter 2026 earnings release, which, while in line with Wall Street estimates, revealed ongoing year-over-year deterioration in sales, earnings, and operating margins, paired with a cautious full-year outlook that left investors uninspired.

Earnings Miss the Mark on Sentiment Despite Meeting Estimates

Badger Meter reported Q2 2026 diluted earnings per share of $1.02, down 13% from $1.17 in the prior-year quarter but matching the consensus analyst estimate of approximately $1.02. Revenue came in at $222.3 million, a 7% decline from $238.1 million a year ago, and slightly above the $220–221 million consensus forecast. While these headline numbers did not constitute a formal miss, the year-over-year contraction in both top- and bottom-line performance weighed heavily on investor sentiment.

Operating earnings fell 12% to $39.4 million, with operating margins compressing 110 basis points to 17.7% from 18.8% in the year-ago period. Gross margin slipped 30 basis points to 40.8%, held within the company's normalized range of 39–42% but pressured by lower sales volumes and project mix effects. Free cash flow fell sharply to $21.9 million from $40.6 million a year earlier, reflecting temporary working capital increases tied to uneven project pacing.

"Flattish" Full-Year Guidance Dampens Recovery Hopes

Perhaps the most significant weight on the stock was management's reaffirmed outlook for full-year organic revenue to be "flattish" compared to 2025 levels, excluding the contribution from the recently acquired UDlive Limited. CEO Kenneth C. Bockhorst emphasized that sequential quarterly improvement was expected through the remainder of 2026, but the cautious tone around annual growth — particularly against a backdrop where some analysts had modeled more robust second-half acceleration — appeared to disappoint the market.

CFO Dan Weltzin also flagged "increasing levels of electronic component cost and availability pressures" stemming from AI and data center build-out demand, signaling that margin headwinds may persist. The combination of tepid growth guidance and ongoing cost pressures gave investors little reason to bid the stock higher in the immediate aftermath of the report.

Segment Dynamics: Utility Water Weakness, Flow Instrumentation a Bright Spot

Utility water sales — Badger Meter's largest segment — declined 8% year-over-year (9% excluding the UDlive acquisition), driven by the uneven ramp of advanced metering infrastructure (AMI) projects. On a positive note, utility water sales improved 8% sequentially from the first quarter, as several previously awarded projects, including the major PRASA initiative in Puerto Rico, began initial product shipments.

Flow instrumentation products provided a relative bright spot, with sales rising 6% year-over-year, supported by broad-based water application demand and emerging orders tied to data center cooling and flow monitoring. However, this segment alone was insufficient to offset the drag from the larger utility water business.

Market Context and Trading Activity

Trading volume in BMI was significantly elevated on Wednesday, running well above the stock's average daily volume, indicating heavy institutional repositioning following the earnings release. The sell-off in Badger Meter shares occurred against a backdrop of broader caution in industrial and water infrastructure names, as investors reassess the pace of municipal capital spending and the potential impact of sustained higher interest rates on project financing timelines.

The magnitude of the decline — pushing below key technical support levels near $138–140 — suggests that momentum-driven selling amplified the fundamental disappointment. The stock had rallied considerably in recent weeks leading into the earnings report, leaving it vulnerable to a sharp reversal when the results and guidance failed to exceed expectations.

Trending AI Robots

For traders seeking systematic, data-driven approaches to navigate volatile markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron provides hundreds of AI-powered trading bots covering thousands of tickers across equities, ETFs, and cryptocurrencies, but only the strongest performers under current market conditions are highlighted in this dedicated section. These bots differ by strategy — from swing trading to trend following — as well as timeframe, performance metrics, and the symbols they trade. The Trending AI Robots section serves as a streamlined discovery tool for traders who want to identify which automated strategies are delivering results right now, without sifting through the entire bot marketplace. Explore the Trending AI Robots page to see which strategies are currently leading the pack.

What Comes Next for BMI

Looking ahead, the key variable for BMI will be whether the company's pipeline of awarded AMI projects materializes on schedule during the second half of 2026. Management has indicated that the cohort of nine previously discussed awarded projects "feels pretty solid," with initial shipments already underway for several. Any positive updates on project ramp timelines could help restore investor confidence.

Additionally, the integration of UDlive — the UK-based sewer line monitoring specialist acquired in May 2026 — will be closely watched, as it expands Badger Meter's beyond-the-meter capabilities. On the risk side, ongoing class action litigation related to prior-period disclosures, electronic component cost inflation, and the inherent unpredictability of municipal procurement cycles all represent uncertainties that could keep the stock range-bound in the near term. The next quarterly report will be a critical checkpoint for whether the recovery narrative remains intact.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BMI

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


BMI in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 22, 2026

BMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where BMI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BMI's RSI Oscillator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 05, 2026. You may want to consider a long position or call options on BMI as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 210 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where BMI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on August 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

BMI moved below its 50-day moving average on August 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMI crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.721) is normal, around the industry mean (4.526). P/E Ratio (31.562) is within average values for comparable stocks, (90.913). Projected Growth (PEG Ratio) (3.390) is also within normal values, averaging (2.166). Dividend Yield (0.012) settles around the average of (0.011) among similar stocks. P/S Ratio (4.498) is also within normal values, averaging (30.382).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

Industry description

This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.

Market Cap

The average market capitalization across the Electronic Equipment/Instruments Industry is 9.47B. The market cap for tickers in the group ranges from 27.54K to 122.53B. KYCCF holds the highest valuation in this group at 122.53B. The lowest valued company is CSEC at 27.54K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Equipment/Instruments Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 8%. MVIS experienced the highest price growth at 46%, while FCUV experienced the biggest fall at -47%.

Volume

The average weekly volume growth across all stocks in the Electronic Equipment/Instruments Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was -85% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 55
Price Growth Rating: 52
SMR Rating: 79
Profit Risk Rating: 78
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
BMI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a maker of flow measurement and control products

Industry ElectronicEquipmentInstruments

Profile
Details
Industry
Electronic Equipment Or Instruments
Address
4545 West Brown Deer Road
Phone
+1 414 355-0400
Employees
2140
Web
https://www.badgermeter.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.